| 摘要 |
<p>The invention features a novel gene, CRX, which encodes a retinal-specific transcriptional activator protein. Mutations within the CRX gene are responsible for cone-rod dystrophy, a retinal degenerative disease. The invention features methods for the detection of CRX mutations, and for the prevention and treatment of retinal degenerative diseases influenced by the CRX gene.</p> |
